Abstract
The following article contains an error: ‘A GLP-1 receptor agonist liraglutide inhibits endothelial cell dysfunction and vascular adhesion molecule expression in an ApoE-/- mouse model’ by Tracey Gaspari, HongBin Liu, Iresha Welungoda, Yunshan Hu, Robert E Widdop, Lotte B Knudsen, Richard W Simpson and Anthony E Dear, published in Diabetes & Vascular Disease Research 2011; 8(2): 117–124, DOI: 10.1177/1479164111404257.
The following corrections apply:
Page 121, left column, the third paragraph, beginning ‘No significant change…’, should be replaced with the following text:
A small but significant decrease in body weight and trend to reduction in systolic blood pressure was noted in the liraglutide treated groups (data shown below).
Data in relation to body weight and systolic blood pressure from the four-week in vivo study.
The authors apologize for this error.